Skip to main content
. 2015 Oct 5;10:6257–6276. doi: 10.2147/IJN.S92449

Figure 7.

Figure 7

(A) Effects of graphene oxide (GO), (B) reduced graphene oxide (rGO), (C) rGO–Ag nanocomposite, and (D) Ag nanoparticles (AgNPs) on the viability of human ovarian cancer cells.

Notes: The viability of A2780 human ovarian cancer cells was determined after 24-hour exposure to different concentrations of GO, rGO, rGO–Ag nanocomposite, and AgNPs using the WST-8 assay. The results are expressed as the mean ± standard deviation of three independent experiments. A significant difference was observed above 50 μM. The viability of treated cells compared to the untreated cells by the Student’s t-test (*P<0.05).